Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of "Moderate Buy" from Brokerages

Key Points

• Henry Schein has a “Moderate Buy” consensus rating from 15 analysts, with nine buys, five holds, and one sell. The average 12-month price target is $92.93, with recent targets ranging from $95 to $112.
• The company exceeded quarterly expectations, reporting $1.27 in EPS versus the $1.24 consensus and $3.46 billion in revenue versus estimates of $3.37 billion. Revenue increased 6.7% year over year, and analysts expect approximately $5.36 in EPS for the current fiscal year.
• HSIC opened at $86.37, near the middle of its 52-week range of $61.94 to $92.18, while institutional investors own 96.62% of outstanding shares.

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has earned a consensus rating of "Moderate Buy" from the fifteen research firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month target price among brokers that have covered the stock in the last year is $92.93.

Several equities analysts have recently commented on HSIC shares. Barrington Research set a $104.00 price target on shares of Henry Schein in a research report on Wednesday, August 5th. Weiss Ratings raised Henry Schein from a "hold (c+)" rating to a "buy (b-)" rating in a report on Friday, August 21st. Piper Sandler upped their price objective on Henry Schein from $91.00 to $95.00 and gave the company an "overweight" rating in a research note on Wednesday, July 29th. Stifel Nicolaus set a $95.00 target price on Henry Schein in a report on Wednesday, August 5th. Finally, Citigroup reiterated a "buy" rating and issued a $112.00 price target (up from $100.00) on shares of Henry Schein in a report on Wednesday, August 5th.

Henry Schein Stock Performance

Henry Schein stock opened at $86.37 on Monday. Henry Schein has a 52 week low of $61.94 and a 52 week high of $92.18. The company has a current ratio of 1.32, a quick ratio of 0.73 and a debt-to-equity ratio of 0.60. The stock has a market cap of $9.63 billion, a P/E ratio of 25.18, a price-to-earnings-growth ratio of 1.53 and a beta of 0.81. The stock has a 50 day moving average of $87.84 and a 200-day moving average of $81.11.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $1.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.24 by $0.03. The business had revenue of $3.46 billion during the quarter, compared to analyst estimates of $3.37 billion. Henry Schein had a net margin of 2.96% and a return on equity of 15.97%. The business's revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.10 earnings per share. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. On average, analysts expect that Henry Schein will post 5.36 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Buckland Partners Management Co LLC bought a new stake in shares of Henry Schein in the 2nd quarter worth approximately $1,036,000. Public Employees Retirement System of Ohio acquired a new position in Henry Schein during the 2nd quarter valued at approximately $2,547,000. Heartland Advisors Inc. bought a new position in Henry Schein during the 4th quarter worth $9,070,000. K.J. Harrison & Partners Inc bought a new position in Henry Schein during the 1st quarter worth $1,253,000. Finally, California State Teachers Retirement System increased its position in Henry Schein by 16.3% in the first quarter. California State Teachers Retirement System now owns 123,992 shares of the company's stock worth $9,138,000 after buying an additional 17,418 shares during the period. 96.62% of the stock is currently owned by institutional investors.

About Henry Schein

Henry Schein, Inc NASDAQ: HSIC is a global provider of health care products and services for dental and medical professionals. The company distributes consumable supplies, equipment, pharmaceuticals, vaccines, and other products used by dental practices, physician offices, clinics, and other health care organizations.

In addition to product distribution, Henry Schein provides technology and business solutions designed to support practice operations. Its offerings include practice-management software, digital dentistry solutions, clinical technologies, equipment services, consulting, and other value-added services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.